创伤性脑损伤患者静脉血栓栓塞发生的影响因素
本研究为横断面研究,回顾性收集2015–2020年一家一级创伤中心收治并接受静脉血栓栓塞预防的818例创伤性脑损伤患者数据,旨在识别与静脉血栓栓塞发生相关的 demographics 与临床变量。总体静脉血栓栓塞发生率为9.1%(深静脉血栓7.6%、肺栓塞3.2%、两者兼有1.7%),深静脉血栓诊断中位时间7天(四分位距4–11)、肺栓塞5天(四分位距3–12)。发生静脉血栓栓塞者更年轻(44岁 vs 54岁,p=0.02)、损伤更重(格拉斯哥昏迷评分7.5 vs 14,p=0.002;损伤严重度评分27 vs 21,p<0.001)、更多为多发伤(55.4% vs 34.0%,p<0.001)、更多需神经外科干预(45.9% vs 30.5%,p=0.007)、更常漏用≥1剂静脉血栓栓塞预防(39.2% vs 28.4%,p=0.04)、更多有静脉血栓栓塞病史(14.9% vs 6.5%,p=0.008)。单因素分析显示漏用4–6剂总量预测最高静脉血栓栓塞风险(OR 4.08,95%CI 1.53–10.86,p=0.005)。作者认为,漏用4剂药物预防这一阈值可能尤为重要,因其可由医疗团队控制,并建议制定机构内方案及电子病历工具以避免漏用,尤其对需手术干预的患者。
要点
- 818例创伤性脑损伤并接受静脉血栓栓塞预防的患者中,总体静脉血栓栓塞发生率9.1%(深静脉血栓7.6%、肺栓塞3.2%、两者兼有1.7%)。
- 发生静脉血栓栓塞者更常漏用≥1剂药物预防(39.2% vs 28.4%,p=0.04)。
- 单因素分析中漏用4–6剂总量预测最高静脉血栓栓塞风险(OR 4.08,95%CI 1.53–10.86,p=0.005)。
- 发生静脉血栓栓塞者损伤更重:格拉斯哥昏迷评分7.5 vs 14(p=0.002),损伤严重度评分27 vs 21(p<0.001)。
- 发生静脉血栓栓塞者更多需神经外科干预(45.9% vs 30.5%,p=0.007)、更多有多发伤(55.4% vs 34.0%,p<0.001)。
适用人群与场景
- 2015–2020年一家一级创伤中心收治并接受静脉血栓栓塞预防的818例创伤性脑损伤患者。
研究设计与关键结果
- 研究类型为横断面研究,数据回顾性收集自2015–2020年一家一级创伤中心收治并接受静脉血栓栓塞预防的818例创伤性脑损伤患者。
- 总体静脉血栓栓塞发生率为9.1%,其中深静脉血栓7.6%、肺栓塞3.2%、两者兼有1.7%。
- 深静脉血栓诊断中位时间为7天(四分位距4–11),肺栓塞诊断中位时间为5天(四分位距3–12)。
- 与未发生静脉血栓栓塞者相比,发生者更年轻(44岁 vs 54岁,p=0.02),损伤更重(格拉斯哥昏迷评分7.5 vs 14,p=0.002;损伤严重度评分27 vs 21,p<0.001)。
- 发生静脉血栓栓塞者更多为多发伤(55.4% vs 34.0%,p<0.001),更常需神经外科干预(45.9% vs 30.5%,p=0.007)。
- 发生静脉血栓栓塞者更常漏用≥1剂静脉血栓栓塞预防(39.2% vs 28.4%,p=0.04),更多有静脉血栓栓塞病史(14.9% vs 6.5%,p=0.008)。
- 单因素分析显示,漏用4–6剂总量预测最高静脉血栓栓塞风险(OR 4.08,95%CI 1.53–10.86,p=0.005)。
证据类型、等级与局限
- 证据类型:横断面研究,数据回顾性收集。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,漏用4剂药物预防这一阈值可能尤为重要,因其可由医疗团队控制。
- 作者建议制定机构内方案及电子病历工具以避免漏用,尤其对需手术干预的患者,可能降低未来静脉血栓栓塞形成的可能性。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Venous thromboembolic (VTE) events are a major concern in trauma and intensive care, with the prothrombotic state caused by traumatic brain injury (TBI) increasing the risk in affected patients. We sought to identify critical demographic and clinical variables and determine their influence on subsequent VTE development in patients with TBI.
METHODS: This was a cross-sectional study with data retrospectively collected from 818 patients with TBI admitted to a level I trauma center in 2015-2020 and placed on VTE prophylaxis.
RESULTS: The overall VTE incidence was 9.1% (7.6% deep vein thrombosis, 3.2% pulmonary embolism, 1.7% both). The median time to diagnosis was 7 days (interquartile range 4-11) for deep vein thrombosis and 5 days (interquartile range 3-12) for pulmonary embolism. Compared with those who did not develop VTE, patients who developed VTE were younger (44 vs. 54 years, p = 0.02), had more severe injury (Glasgow Coma Scale 7.5 vs. 14, p = 0.002, Injury Severity Score 27 vs. 21, p < 0.001), were more likely to have experienced polytrauma (55.4% vs. 34.0%, p < 0.001), more often required neurosurgical intervention (45.9% vs. 30.5%, p = 0.007), more frequently missed ≥ 1 dose of VTE prophylaxis (39.2% vs. 28.4%, p = 0.04), and were more likely to have had a history of VTE (14.9% vs. 6.5%, p = 0.008). Univariate analysis demonstrated that 4-6 total missed doses predicted the highest VTE risk (odds ratio 4.08, 95% confidence interval 1.53-10.86, p = 0.005).
CONCLUSIONS: Our study highlights patient-specific factors that are associated with VTE development in a cohort of patients with TBI. Although many of these are unmodifiable patient characteristics, a threshold of four missed doses of chemoprophylaxis may be particularly important in this critical patient population because it can be controlled by the care team. Development of intrainstitutional protocols and tools within the electronic medical record to avoid missed doses, particularly among patients who require operative interventions, may result in decreasing the likelihood of future VTE formation.
参考来源
- Cole KL, Nguyen S, Gelhard S, et al. Factors Associated with Venous Thromboembolism Development in Patients with Traumatic Brain Injury. Neurocrit Care. 2023. PMID: 37421493. doi:10.1007/s12028-023-01780-8
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。